PERtuzumab-trastuzumab plus lEetrozoLe In endocrine Sensitive breast cancer: a phase II neoAdjuvant study
Phase of Trial: Phase II
Latest Information Update: 28 Sep 2016
At a glance
- Drugs Pertuzumab (Primary) ; Trastuzumab (Primary) ; Letrozole
- Indications Advanced breast cancer; Early breast cancer
- Focus Therapeutic Use
- Acronyms PER-ELISA
- 16 Sep 2016 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
- 16 Sep 2016 Planned primary completion date changed from 1 Aug 2016 to 1 Oct 2017.
- 17 Jul 2014 New trial record